Rhythm Pharmaceuticals (RYTM)
Markets IMCIVREE and develops MC4R agonists for rare neuroendocrine obesity disorders.
$99.27
After hours−0.16 (−0.16%)
At close$99.43(+0.60%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.72
Revenue estimate
$84.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.72−$0.81−$0.75−$0.82−$0.73−$0.83−$0.73Pending
Estimate−$0.69−$0.69−$0.66−$0.72−$0.79−$0.86−$0.81−$0.72
Surprise−4.3%−17.4%−13.6%−13.9%+7.6%+3.5%+9.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$41.8M$32.7M$48.5M$51.3M$57.3M$60.1M$71.3MPending
Estimate$38.5M$43.3M$51.3M$56.0M$56.2M$55.8M$67.7M$84.8M
Surprise+8.7%−24.4%−5.5%−8.4%+1.9%+7.8%+5.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.23 | — | — |
| Sep 2027 | $0.02 | — | — |
| Jun 2027 | −$0.36 | — | — |
| Mar 2027 | −$0.62 | — | — |
| Dec 2026 | −$0.72 | — | — |
| Nov 2026 | −$0.72 | — | — |
| Aug 2026 | −$0.81 | −$0.73 | +9.6% |
| May 2026 | −$0.86 | −$0.83 | +3.5% |
| Feb 2026 | −$0.79 | −$0.73 | +7.6% |
| Nov 2025 | −$0.72 | −$0.82 | −13.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Oct 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.23 | — | — | $175.6M | — | — | — |
| Sep 2027 | $0.02 | — | — | $151.9M | — | — | — |
| Jun 2027 | −$0.36 | — | — | $125.9M | — | — | — |
| Mar 2027 | −$0.62 | — | — | $101.4M | — | — | — |
| Dec 2026 | −$0.72 | — | — | $100.7M | — | — | — |
| Nov 3, 2026 | −$0.72 | — | — | $84.8M | — | — | — |
| Aug 4, 2026 | −$0.81 | −$0.73 | +9.6% | $67.7M | $71.3M | +5.3% | +2.9% |
| May 5, 2026 | −$0.86 | −$0.83 | +3.5% | $55.8M | $60.1M | +7.8% | +7.9% |
| Feb 26, 2026 | −$0.79 | −$0.73 | +7.6% | $56.2M | $57.3M | +1.9% | −1.1% |
| Nov 4, 2025 | −$0.72 | −$0.82 | −13.9% | $56.0M | $51.3M | −8.4% | −7.7% |
| Aug 5, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Mar 1, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 3, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 3, 2021 | |||||||
| May 3, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 2, 2020 | |||||||
| Aug 3, 2020 | |||||||
| May 4, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Nov 1, 2019 | |||||||
| Jul 29, 2019 | |||||||
| May 3, 2019 | |||||||
| Mar 8, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Oct 5, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |